Literature DB >> 32496543

Differential Antibody Recognition of H3N2 Vaccine and Seasonal Influenza Virus Strains Based on Age, Vaccine Status, and Sex in the 2017-2018 Season.

Rebecca L Ursin1, Hsuan Liu2, Harrison R Powell2, Jason W Westerbeck2, Kathryn Shaw-Saliba3, Kristyn E Sylvia2, Katherine J Fenstermacher3, Tom Mehoke4, Peter Thielen4, Richard E Rothman3, Andrew Pekosz2, Sabra L Klein1,2.   

Abstract

BACKGROUND: An antigenic mismatch between the vaccine and circulating H3N2 strains was hypothesized to contribute to the severity of the 2017-2018 season in North America.
METHODS: Serum and nasal washes were collected from influenza positive and negative patients during the 2017-2018 season to determine neutralizing antibody (nAb) titers and for influenza virus sequencing, respectively.
RESULTS: The circulating and vaccine H3N2 virus strains were different clades, with the vaccine strain being clade 3C.2a and the circulating viruses being 3C.2a2 or 3C.3a. At enrollment, both the H3N2 negative and positive patients had greater nAb titers to the egg-adapted vaccine virus compared to the cell-grown vaccine but the H3N2-negative population had significantly greater titers to the circulating 3C.2a2. Among H3N2-positive patients, vaccination, younger age, and female sex were associated with greater nAb responses to the egg-adapted vaccine H3N2 virus but not to the cell-grown vaccine or circulating viruses.
CONCLUSIONS: For the 2017-2018 circulating viruses, mutations introduced by egg adaptation decreased vaccine efficacy. No increased protection was afforded by vaccination, younger age, or female sex against 2017-2018 circulating H3N2 viruses.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  circulating influenza strain; egg adaptation; human surveillance; neutralizing antibody; seasonal influenza vaccine; sex differences

Mesh:

Substances:

Year:  2020        PMID: 32496543      PMCID: PMC7488199          DOI: 10.1093/infdis/jiaa289

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010).

Authors:  Sundar S Shrestha; David L Swerdlow; Rebekah H Borse; Vimalanand S Prabhu; Lyn Finelli; Charisma Y Atkins; Kwame Owusu-Edusei; Beth Bell; Paul S Mead; Matthew Biggerstaff; Lynnette Brammer; Heidi Davidson; Daniel Jernigan; Michael A Jhung; Laurie A Kamimoto; Toby L Merlin; Mackenzie Nowell; Stephen C Redd; Carrie Reed; Anne Schuchat; Martin I Meltzer
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079

2.  A Tale of Two Mutations: Beginning to Understand the Problems with Egg-Based Influenza Vaccines?

Authors:  Kanta Subbarao; Ian Barr
Journal:  Cell Host Microbe       Date:  2019-06-12       Impact factor: 21.023

3.  Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018.

Authors:  Katia J Bruxvoort; Yi Luo; Bradley Ackerson; Hilary C Tanenbaum; Lina S Sy; Ashesh Gandhi; Hung Fu Tseng
Journal:  Vaccine       Date:  2019-08-22       Impact factor: 3.641

4.  Influenza A Virus M2 Protein Apical Targeting Is Required for Efficient Virus Replication.

Authors:  Nicholas Wohlgemuth; Andrew P Lane; Andrew Pekosz
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

5.  Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses.

Authors:  Bin Zhou; Matthew E Donnelly; Derek T Scholes; Kirsten St George; Masato Hatta; Yoshihiro Kawaoka; David E Wentworth
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

6.  Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin.

Authors:  Yi Pu Lin; Xiaoli Xiong; Stephen A Wharton; Stephen R Martin; Peter J Coombs; Sebastien G Vachieri; Evangelos Christodoulou; Philip A Walker; Junfeng Liu; John J Skehel; Steven J Gamblin; Alan J Hay; Rodney S Daniels; John W McCauley
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

7.  Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility.

Authors:  Nicholas C Wu; Huibin Lv; Andrew J Thompson; Douglas C Wu; Wilson W S Ng; Rameshwar U Kadam; Chih-Wei Lin; Corwin M Nycholat; Ryan McBride; Weiwen Liang; James C Paulson; Chris K P Mok; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2019-05-28       Impact factor: 21.023

8.  Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018.

Authors:  Patricia A Jorquera; Vasiliy P Mishin; Anton Chesnokov; Ha T Nguyen; Brian Mann; Rebecca Garten; John Barnes; Erin Hodges; Juan De La Cruz; Xiyan Xu; Jackie Katz; David E Wentworth; Larisa V Gubareva
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

9.  Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females.

Authors:  Tanvi Potluri; Ashley L Fink; Kristyn E Sylvia; Santosh Dhakal; Meghan S Vermillion; Landon Vom Steeg; Sharvari Deshpande; Harish Narasimhan; Sabra L Klein
Journal:  NPJ Vaccines       Date:  2019-07-12       Impact factor: 7.344

Review 10.  H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.

Authors:  James D Allen; Ted M Ross
Journal:  Hum Vaccin Immunother       Date:  2018-05-14       Impact factor: 3.452

View more
  3 in total

1.  Age-specific effects of vaccine egg adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination.

Authors:  Feng Liu; F Liaini Gross; Stacie N Jefferson; Crystal Holiday; Yaohui Bai; Li Wang; Bin Zhou; Min Z Levine
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

2.  Antigenic Distance between North American Swine and Human Seasonal H3N2 Influenza A Viruses as an Indication of Zoonotic Risk to Humans.

Authors:  Carine K Souza; Tavis K Anderson; Jennifer Chang; Divya Venkatesh; Nicola S Lewis; Andrew Pekosz; Kathryn Shaw-Saliba; Richard E Rothman; Kuan-Fu Chen; Amy L Vincent
Journal:  J Virol       Date:  2021-11-10       Impact factor: 6.549

3.  Greater Breadth of Vaccine-Induced Immunity in Females than Males Is Mediated by Increased Antibody Diversity in Germinal Center B Cells.

Authors:  Rebecca L Ursin; Santosh Dhakal; Hsuan Liu; Sahana Jayaraman; Han-Sol Park; Harrison R Powell; Morgan L Sherer; Kirsten E Littlefield; Ashley L Fink; Zexu Ma; Alice L Mueller; Allison P Chen; Kumba Seddu; Yishak A Woldetsadik; Patricia J Gearhart; H Benjamin Larman; Robert W Maul; Andrew Pekosz; Sabra L Klein
Journal:  mBio       Date:  2022-07-20       Impact factor: 7.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.